- Lee Schwartzberg, MD, FACP, Chairman, President, and Chief Medical Officer
- Kurt Tauer, MD
- Michael Choukas, Chief Executive Officer
- Chris McLean
Lee Schwartzberg, MD, FACP, Chairman, President, and Chief Medical Officer
Lee Schwartzberg, MD, FACP, serves as President and Chief Medical Officer for Vector Oncology. He directs all clinical research initiatives, provides leadership, clinical oversight and management for Vector Oncology and its services. He continues his work as a medical oncologist and hematologist, senior partner and medical director in an ever-growing community-based private practice at The West Cancer Center. Dr. Schwartzberg is founding Editor-in-Chief for Oncologystat.com and was the founding Editor-in-Chief for Community Oncology Journal. He serves as the Division Chief of Hematology/Oncology and Professor of Medicine at the University of Tennessee Health Science Center. Dr. Schwartzberg also serves on the Board of Directors for the National Comprehensive Cancer Network. His research interests include breast cancer, supportive care and developmental therapeutics, having published over 110 peer-reviewed publications.
After attending medical school at New York Medical College, he completed his residency and fellowship at Cornell University and Memorial Sloan-Kettering Cancer Center. He has been the recipient of numerous honors/awards for his work in the field of oncology, most recently, Castle Connelly Top Doctors and the Memphis Business Journal, Health Care Hero for Health Care Innovations.
Kurt Walter Tauer, MD
Kurt Walter Tauer is an oncologist at The West Cancer Center, a Clinical Instructor of Medicine at the University of Tennessee, and head of the Palliative Care Committee at Baptist Memorial Hospital; all in Memphis. He has served on the local Board of Directors of the American Cancer Society and on the executive committee of the Baptist Cancer Institute, and as Chairman of the Cancer Committee of Baptist Memorial Hospital in Memphis. He has been past president of Community Oncology Alliance and serves on the Board of Directors of the Cancer Clinics of Excellence.
Dr. Tauer graduated cum laude from Saint Louis University School of Medicine. He completed his residency in internal medicine at Baptist Memorial Hospital in Memphis, followed by a fellowship in Medical Oncology at Memorial Sloan-Kettering Cancer Center in New York City.
Dr. Tauer has co-authored more than 45 abstracts and two dozen papers, which have appeared in such publications as Proceedings from the American Society, Journal of Clinical Oncology, Cancer Treatment Report, and The New England Journal of Medicine. His research activities have focused largely on the analysis of high-dose chemotherapy and peripheral blood stem cell infusion and on the study of various methods of cell therapy.
Michael Choukas, Chief Executive Officer
Michael Choukas was appointed CEO of Vector Oncology in January, 2014, and has worked with the company as a strategic advisor since May, 2012. Prior to joining Vector Oncology, he served as Partner of private equity firm The Watermill Group. Previously, Mike served as President and CEO of Oncopartners, a Latin American oncology development services company, which he founded in 2006. Prior to his work with Oncopartners, he was a member of the leadership team of United Biosource Corporation (UBC) where he served as Executive Vice President of Strategy and Operations and Executive Chairman of the Late Stage Group from 2004 to 2006. In 1996, Mike founded Scirex Corporation and served as Scirex Chairman and CEO until 2003. He held senior leadership positions as Chairman and CEO of Springborn Laboratories, Executive Vice President of Dun and Bradstreet Software and Services, and as a Partner at Bain & Company, where he contributed to the leadership of Bain’s software and M&A practice areas. Mike began his career serving on the staff of the US Senate Committee on Environment and Public Works and then as Legislative Director for US Senator Patrick Leahy.
Mike currently serves as Chairman of the Board of Trustees for Vermont Academy, and as a Director of Tubes Holdco Ltd, a Watermill portfolio company. He has been a member of the Alumni Council of Dartmouth College. He holds an MBA from Harvard University and a BA in Economics from Dartmouth College.
Chris McLean, Executive Vice President of Finance for Methodist Healthcare
Chris McLean was named Executive Vice President of Finance for Methodist Healthcare in October 2001. Prior to that appointment, he was Vice President of Finance for Methodist.
McLean began his healthcare career at Methodist in 1984 in corporate finance. He left in 1992 to work for several health systems in east Tennessee. He returned to Methodist in 1998 as Vice President of the Mississippi division.
He holds a Bachelor of Science in Accounting from Christian Brothers University and a Masters of Business Administration from the University of Memphis.
McLean is a member of the Tennessee Society of Certified Public Accountants and the Healthcare Financial Management Association. He serves on the boards of Wesley Housing and Health Choice.